Back to Journals » Drug Design, Development and Therapy » Volume 12

Original Research

HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

       
Total article views   HTML views PDF downloads Totals
15,546 Dovepress* 14,496+ 1,044 15,540
PubMed Central* 1,050 269 1,319
Totals 15,546 1,313 16,859
*Since 23 July 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 1 2

View citations on PubMed Central and Google Scholar